- Home
- ACLX vs BNL Comparison
ACLX vs BNL Comparison
Compare ACLX & BNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- BNL
- Stock Information
- Founded
- ACLX 2015
- BNL 2007
- Country
- ACLX United States
- BNL United States
- Employees
- ACLX N/A
- BNL N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- BNL Real Estate Investment Trusts
- Sector
- ACLX Health Care
- BNL Real Estate
- Exchange
- ACLX Nasdaq
- BNL Nasdaq
- Market Cap
- ACLX 3.3B
- BNL 3.1B
- IPO Year
- ACLX 2022
- BNL 2020
- Fundamental
- Price
- ACLX $61.93
- BNL $15.96
- Analyst Decision
- ACLX Strong Buy
- BNL Hold
- Analyst Count
- ACLX 13
- BNL 6
- Target Price
- ACLX $111.55
- BNL $18.40
- AVG Volume (30 Days)
- ACLX 1.1M
- BNL 1.7M
- Earning Date
- ACLX 05-08-2025
- BNL 07-29-2025
- Dividend Yield
- ACLX N/A
- BNL 7.22%
- EPS Growth
- ACLX N/A
- BNL N/A
- EPS
- ACLX N/A
- BNL 0.60
- Revenue
- ACLX $76,809,000.00
- BNL $435,124,000.00
- Revenue This Year
- ACLX N/A
- BNL $4.81
- Revenue Next Year
- ACLX $119.90
- BNL $4.76
- P/E Ratio
- ACLX N/A
- BNL $26.73
- Revenue Growth
- ACLX N/A
- BNL 1.37
- 52 Week Low
- ACLX $47.86
- BNL $13.96
- 52 Week High
- ACLX $107.37
- BNL $19.15
- Technical
- Relative Strength Index (RSI)
- ACLX 50.64
- BNL 51.84
- Support Level
- ACLX $60.67
- BNL $15.28
- Resistance Level
- ACLX $64.78
- BNL $15.99
- Average True Range (ATR)
- ACLX 4.19
- BNL 0.29
- MACD
- ACLX 0.35
- BNL 0.01
- Stochastic Oscillator
- ACLX 52.83
- BNL 68.95
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.
About BNL Broadstone Net Lease Inc.
Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.